ITMI931104A1 - Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo - Google Patents

Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo

Info

Publication number
ITMI931104A1
ITMI931104A1 IT93MI001104A ITMI931104A ITMI931104A1 IT MI931104 A1 ITMI931104 A1 IT MI931104A1 IT 93MI001104 A IT93MI001104 A IT 93MI001104A IT MI931104 A ITMI931104 A IT MI931104A IT MI931104 A1 ITMI931104 A1 IT MI931104A1
Authority
IT
Italy
Prior art keywords
hyperinsulinism
fighting
preparation
form suitable
pharmaceutical form
Prior art date
Application number
IT93MI001104A
Other languages
English (en)
Inventor
Massimiliano Savioli
Leopoldo Silvestroni
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to ITMI931104A priority Critical patent/IT1271354B/it
Publication of ITMI931104A0 publication Critical patent/ITMI931104A0/it
Publication of ITMI931104A1 publication Critical patent/ITMI931104A1/it
Application granted granted Critical
Publication of IT1271354B publication Critical patent/IT1271354B/it

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

N-acil-cisteine e loro analoghi, ad esempio la N-acetil-cisteina i suoi esteri o sali, sono utili nel trattamento dell'iperinsulinismo.La somministrazione di N-acetil-cisteina, anche quale unico farmaco, in dosi comprese tra 100 e 500 mg/die riduce significativamente l'iperinsulinismo ed il quadro morboso ad esso collegato.
ITMI931104A 1993-05-28 1993-05-28 Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi IT1271354B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI931104A IT1271354B (it) 1993-05-28 1993-05-28 Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI931104A IT1271354B (it) 1993-05-28 1993-05-28 Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi

Publications (3)

Publication Number Publication Date
ITMI931104A0 ITMI931104A0 (it) 1993-05-28
ITMI931104A1 true ITMI931104A1 (it) 1994-11-28
IT1271354B IT1271354B (it) 1997-05-27

Family

ID=11366278

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI931104A IT1271354B (it) 1993-05-28 1993-05-28 Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi

Country Status (1)

Country Link
IT (1) IT1271354B (it)

Also Published As

Publication number Publication date
ITMI931104A0 (it) 1993-05-28
IT1271354B (it) 1997-05-27

Similar Documents

Publication Publication Date Title
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
ZA200408649B (en) Opthamological use of roflumilast for the treatment of diseases of the eye
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
CA2240329A1 (en) Improved delivery of multiple doses of medications
IT1276689B1 (it) Forma farmaceutica solida ad uso orale
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
ES2099275T3 (es) Comprimido multiparticulas de desleimiento rapido.
MX9203443A (es) Una forma de dosis para el suministro retardado de un farmaco.
ATE75604T1 (de) Antiphlogistika enthaltende pharmazeutische formulierungen mit gesteuerter freigabe.
DE69805001T2 (de) Osmotische darreichungsform mit zwei mantelschichten
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
AU2223095A (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
IT1244636B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
JP2005525329A5 (it)
TR199800765T2 (xx) Otoim�n hastal�klar�n tedavisine mahsus bir farmas�tik bile�im
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI931104A1 (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo
EP1352657A4 (en) INTERFERON-BASED EFFECT POTENTIALIZING THERAPEUTICS
CA2474703A1 (en) Therapeutic agent of glaucoma comprising bunazosin and prostaglandins

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970825